Montgomery Andresen joins from T-Cypher Bio; Follows breakthrough non-human primate data demonstrating deep B-cell depletion without cytokine release; Commit is p ...
Follow-up on phase 1 study of AT101, a novel anti-CD19 chimeric antigen receptor cell therapy (CAR-T) in patients with relapsed or refractory (r/r) b-cell non-Hodgkin lymphoma. This is an ASCO Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results